Anthony V. Schapira
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Mitochondrial function is impaired in long COVID patients.
Journal: Annals of medicine
Published: August 12, 2025
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.
Journal: Nature medicine
Published: June 16, 2025
Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials.
Journal: NPJ Parkinson's disease
Published: April 15, 2025
Prospects for Disease Slowing in Parkinson Disease.
Journal: Annual review of pharmacology and toxicology
Published: August 01, 2024
Lysosomal-endolysomal dysfunction and neurodegenerative diseases.
Journal: Neurobiology of disease
Published: August 25, 2022
Glucocerebrosidase mutations and Parkinson disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: May 27, 2022
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.
Journal: Neurobiology of disease
Published: December 05, 2021
Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways.
Journal: Free radical biology & medicine
Published: May 18, 2021
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease.
Journal: CNS drugs
Published: July 02, 2020
Pathogenetic insights into young-onset Parkinson disease.
Journal: Nature reviews. Neurology
Published: March 27, 2020
Last Updated: 09/26/2026